Nonetheless, they necessitate neuro-radiological and ophthalmological surveillance, with intervals that vary (quarterly, semi-annually, or annually) contingent upon the tumor’s location, documented symptoms, and the presence or absence of NF-1 association. This evidence concerns the gene NF1 and neoplasm.